Clinical Expertise
Overview of Clinical Impact
Dr. (Prof.) Vijay Patil has provided care to over 100,000 cancer patients throughout his career. His clinical experience encompasses supervising immunotherapy administration in more than 1,000 patients, targeted therapies in over 10,000 patients, metronomic chemotherapy in more than 15,000 patients, and conventional chemotherapy in over 50,000 patients. He has pioneered numerous novel treatment regimens and clinical criteria that have significantly enhanced treatment efficacy while reducing costs for patients.
His innovations include the Patil criteria for borderline resectability, safety protocols for TPF (DCF) regimen administration in head and neck malignancies, multiple metronomic regimen developments, affordable immunotherapy protocols, combination chemo-targeted regimens for driver-mutated lung cancers, adjuvant strategies for penile malignancies, low-dose bevacizumab-CCNU combinations for gliomas, safety guidelines for PCV regimen in low-intermediate grade gliomas, and telemedicine follow-up systems in oncology care.
Dr. (Prof.) Vijay Patil offers advanced and individualized cancer care, including CAR T-Cell Therapy, Bone Marrow & Stem Cell Transplantation, Immunotherapy, Targeted Therapy, and Chemotherapy.



